Kidney | Non Therapeutic | Supportive Care
Kidney Disease in Patients Receiving Immune Checkpoint Inhibitor Therapy
Volunteers
Health Professionals
What is the purpose of this trial?
The overall goal of this project is to provide clinicians with non-invasive acute kidney injury (AKI) biomarkers in patients who develop kidney injury while on Immune Checkpoint Inhibitor therapy and to understand the impact of early acute kidney injury (AKI)/acute interstitial nephritis (AIN) and other predictors on long-term chronic kidney disease risk in cancer survivors.
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Last Updated08/15/2024
- Study HIC#2000033212